Adolescent Epstein–Barr virus–associated cholestatic jaundice with porta hepatis/pancreatic head lymphadenopathy and transient CA 19-9 elevation: a case report
Frontiers in Pediatrics · 16.03.2026 · 14
DOI: 10.3389/fped.2026.1760882 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 16.03.2026. Verfasst von Ying Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yibin Hospital Affiliated to Children's Hospital of Chongqing Medical University, Yibin, China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cholestatic jaundice is uncommon in adolescents. Epstein–Barr virus (EBV)–related inflammatory lymphadenopathy can mimic malignant biliary obstruction and cause a transient rise in carbohydrate antigen 19-9 (CA 19-9), complicating diagnosis. Case presentation A previously healthy 15-year-old girl presented with 6 days of jaundice and dark urine without fever. Physical examination showed moderate generalized jaundice with mild scleral icterus; multiple mobile, non-tender lymph nodes in the bilateral cervical regions and right post-auricular area (largest ∼2 × 2 cm); palpable liver and spleen; and mild right upper-quadrant tenderness with equivocal Murphy's sign. Initial tests showed a cholestatic pattern (total/direct bilirubin 102.4/67.7 μmol/L at the referring hospital; and 133.2/126.3 μmol/L on admission) with elevated ALP/GGT and total bile acids. CT suggested a porta hepatis-to-pancreatic-head soft-tissue density with mild intrahepatic ductal prominence; CA 19-9 was 117.7 U/mL [ref <37 U/mL]. EBV POCT was positive; EBV DNA was detected at low level. MRI/MRCP (2025-09-29) showed no obvious biliary obstruction. After MRCP excluded fixed biliary obstruction, the patient improved with conservative management (diagnostic evaluation, close monitoring, and symptom-directed care) without invasive intervention; CA 19-9 declined. No causal inference regarding any medication effect should be drawn, and we do not recommend self-medication or routine off-label/unlicensed use of cholestasis-directed agents for EBV infection. In immunocompetent hosts, EBV-related lymphadenopathy is usually self-limited, and this case does not represent EBV-associated lymphoproliferative disease.
Conclusion
EBV-related cholestatic hepatitis in adolescents can present with transient CA 19-9 elevation and reactive porta hepatis/pancreatic head lymphadenopathy, mimicking malignant obstruction. Serial laboratory and imaging assessments—particularly MRCP—together with conservative management may obviate unnecessary invasive procedures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Yibin Hospital Affiliated to Children's Hospital of Chongqing Medical University, Yibin, China.
- Department of Gastroenterology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical Univers…
Zitieren
APA
Chen, Y., Liu, B., & Zhu, X. (2026). Adolescent Epstein–Barr virus–associated cholestatic jaundice with porta hepatis/pancreatic head lymphadenopathy and transient CA 19-9 elevation: a case report. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1760882
Vancouver
Chen Y, Liu B, Zhu X. Adolescent Epstein–Barr virus–associated cholestatic jaundice with porta hepatis/pancreatic head lymphadenopathy and transient CA 19-9 elevation: a case report. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1760882
BibTeX
@article{Chen2026,
author = {Chen, Ying and Liu, Bo and Zhu, Xiaoyu},
title = {Adolescent Epstein–Barr virus–associated cholestatic jaundice with porta hepatis/pancreatic head lymphadenopathy and transient CA 19-9 elevation: a case report},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1760882}
}
EUVIMED